REFLAB ApS: Financial statements 2021
CVR: 15322586
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
REFLAB ApS (CVR 15322586) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 3,435,373 and a net result of DKK -340,962 compared with DKK -888,467 the year before. That is an increase of 85.6% compared with the year before. Equity in the 2021 report amounted to DKK 2,086,902. The solvency ratio was 35.8%. The company had 7 employees in the financial year.
- Gross Profit
- DKK 3,435,373
- Profit/Loss
- DKK -340,962
- Equity
- DKK 2,086,902
- Total Assets
- DKK 5,823,136
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 3.4 mio. | -341 t. | 2.1 mio. | 7 |
| 2020 | - | 1.9 mio. | -888 t. | 2.4 mio. | 6 |
| 2019 | - | 6.9 mio. | 3.1 mio. | 3.3 mio. | 6 |
| 2018 | - | 3.3 mio. | -426 t. | 242 t. | 8 |
| 2017 | - | 2.8 mio. | -1 mio. | 669 t. | 7 |
Official annual report
Find more companies like REFLAB ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
REFLAB ApS has published its annual report for 2020. Gross profit came to DKK 1,851,080, and the net result was DKK -888,467.
About REFLAB ApS
REFLAB ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 1991. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named REFERENCELABORATORIET ApS. The management consists of Gert Pynt Andersen and Katrine Baumann Markussen. The company is owned by R-Biopharm AG. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK 4,582,184 and a net result of DKK -1,792,430 compared with DKK 652,577 the year before. Equity in the 2025 report amounted to DKK -635,048.